Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment

被引:1
|
作者
Firnhaber, Jonathon M. [1 ]
机构
[1] East Carolina Univ, Brody Sch Med, Greenville, NC 27834 USA
关键词
PRIMARY-CARE; SKIN; MANAGEMENT; RISK;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Keratinocyte carcinoma, traditionally referred to as nonmelanoma skin cancer, includes basal cell and cutaneous squamous cell carcinoma and is the most common skin cancer malignancy found in humans. The U.S. Preventive Services Task Force recommends counseling about minimizing exposure to ultraviolet radiation for people aged six months to 24 years with fair skin types to decrease their risk of skin cancer. Routine screening for skin cancer is controversial. The U.S. Preventive Services Task Force concludes that current evidence is insufficient to assess the balance of benefits and harms of a routine whole-body skin examination to screen for skin cancer. Basal cell carcinoma commonly appears as a shiny, pearly papule with a smooth surface, rolled borders, and arborizing telangiectatic surface vessels. Cutaneous squamous cell carcinoma commonly appears as a firm, smooth, or hyperkeratotic papule or plaque, and may have central ulceration. Initial tissue sampling for diagnosis is a shave technique if the lesion is raised, or a punch biopsy of the most abnormal-appearing area of skin. High-risk factors for recurrence and metastasis include prior tumors, ill-defined borders, aggressive histologic patterns, and perineural invasion. Mohs micrographic surgery has the lowest recurrence rate among treatments but is best considered for large, high-risk tumors or tumors in sensitive anatomic locations. Smaller, lower-risk tumors are treated with surgical excision, electrodesiccation and curettage, or cryotherapy. Topical imiquimod and fluorouracil are also treatment options for superficial basal cell carcinoma and squamous cell carcinoma in situ. There are no clear guidelines for follow up after an index keratinocyte carcinoma, but monitoring for recurrence is important because the five-year risk of subsequent skin cancer is 41%. After more than one diagnosis, the five-year risk increases to 82%. Copyright (C) 2020 American Academy of Family Physicians.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 50 条
  • [1] Diagnosis and treatment of basal cell and squamous cell carcinomas
    Stulberg, DL
    Crandell, B
    Fawcett, RS
    AMERICAN FAMILY PHYSICIAN, 2004, 70 (08) : 1481 - 1488
  • [2] Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas
    Wan, Jun
    Dai, Hongji
    Zhang, Xiaoli
    Liu, Sheng
    Lin, Yuan
    Somani, Ally-Khan
    Xie, Jingwu
    Han, Jiali
    GENES & DISEASES, 2021, 8 (02) : 181 - 192
  • [3] PLASMINOGEN ACTIVATION BY CUTANEOUS SQUAMOUS AND BASAL-CELL CARCINOMAS
    SAPPINO, AP
    HIRSCHEL, S
    MASOUYE, I
    HUARTE, J
    VASSALLI, JD
    SAURAT, JH
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (06) : 1000 - 1000
  • [4] Cutaneous Basal Cell Carcinomas and Squamous Cell Carcinomas Frequently Harbor TERT Promoter Mutations
    Murali, R.
    Griewank, K. G.
    Schilling, B.
    Schimming, T.
    Moller, I.
    Moll, I.
    Schwamborn, M.
    Sucker, A.
    Zimmer, L.
    Schadendorf, D.
    Hillen, U.
    MODERN PATHOLOGY, 2014, 27 : 139A - 139A
  • [5] Radiotherapy for Cutaneous Squamous and Basal Cell Carcinomas of the Head and Neck
    Mendenhall, William M.
    Amdur, Robert J.
    Hinerman, Russell W.
    Cognetta, Armand B.
    Mendenhall, Nancy P.
    LARYNGOSCOPE, 2009, 119 (10): : 1994 - 1999
  • [6] Cutaneous Basal Cell Carcinomas and Squamous Cell Carcinomas Frequently Harbor TERT Promoter Mutations
    Murali, R.
    Griewank, K. G.
    Schilling, B.
    Schimming, T.
    Moller, I.
    Moll, I.
    Schwamborn, M.
    Sucker, A.
    Zimmer, L.
    Schadendorf, D.
    Hillen, U.
    LABORATORY INVESTIGATION, 2014, 94 : 139A - 139A
  • [7] Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas
    Abdou, Asmaa Gaber
    Maraee, Alaa Hassan
    El-Sayed, Eman Mostafa Mohamed
    Elnaidany, Nada Farag
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2011, 15 (06) : 394 - 401
  • [8] Basal Cell and Squamous Cell Carcinomas
    Beier, C.
    Kaufmann, R.
    AKTUELLE DERMATOLOGIE, 2005, 31 (05) : 211 - 216
  • [9] Hotspot mutation of the Brm gene in cutaneous squamous cell and basal cell carcinomas
    Moloney, F. J.
    Lyons, J. G.
    Bock, V.
    Huang, X. X.
    Bugeja, M.
    Halliday, G. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (12) : 2909 - 2909
  • [10] Diagnosis and Treatment of Basal Cell and Squamous Cell Carcinoma
    Firnhaber, Jonathon M.
    AMERICAN FAMILY PHYSICIAN, 2012, 86 (02) : 161 - 168